PMC5923221_01
Preoperative MRCP, MRI, and CT detection.. Notes: MRCP, MRI, and CT examinations were performed before surgery. (A) The mass was located in the hepatic hilum, filling the defect of the middle CBD, with dilatation of the intrahepatic and extrahepatic bile duct (red arrow). (B) Upper abdominal CT, both sweep phase and enhanced in the arterial phase. The tumor has an obvious reinforcement in the arterial phase.. Abbreviations: CBD, common bile duct; CT, computed tomography; MRCP, magnetic resonance cholangiopancreatography; MRI, magnetic resonance imaging.
ott-11-2295Fig1.jpg
PMC5923221_01_ott-11-2295Fig1.jpg
f1-ott-11-2295
T2-weighted image (Figure 1A). The tumor had an inhomogeneous enhancement after enhancement during the CT detection (Figure 1B). The blood biochemical tests showed the following: alanine aminotransferase 113 U/L, aspartate transaminase 77 U/L, carbohydrate antigen 19-9 (CA19-9) 64.61 IU/mL, without any other abnormalities.